Discontinuation of vascular therapeutics during the COVID-19 pandemic first wave in France.

J Med Vasc

Department of Vascular Medicine, CHU Rennes, 35033 Rennes cedex 9, France; Université de Rennes 1, INSERM CIC 1414, 35033 Rennes cedex 9, France. Electronic address:

Published: April 2021

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816936PMC
http://dx.doi.org/10.1016/j.jdmv.2021.01.002DOI Listing

Publication Analysis

Top Keywords

discontinuation vascular
4
vascular therapeutics
4
therapeutics covid-19
4
covid-19 pandemic
4
pandemic wave
4
wave france
4
discontinuation
1
therapeutics
1
covid-19
1
pandemic
1

Similar Publications

Background: Migraine is a neurological disorder characterized by severe, unilateral, pulsating headaches with visual, olfactory, and auditory hypersensitivity, as well as autonomic symptoms. Currently, triptans are the standard treatment, but they often fail to relieve symptoms. Herbal medicines are alternative treatments to overcome these limitations.

View Article and Find Full Text PDF

Aims: Data on the early use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) in patients with acute heart failure (HF) are conflicting, and mostly evaluating soft endpoints (i.e., indices of congestion, renal function, ejection fraction, and diuresis).

View Article and Find Full Text PDF

Electrolyte imbalance management is crucial in diverse clinical scenarios, with intravenous potassium repletion often required. High-concentration infusions can pose severe complications if extravasation occurs, leading to phlebitis, local tissue damage, or in severe cases, cutaneous necrosis. This risk is elevated in geriatric patients due to factors like reduced tissue elasticity and sensitivity.

View Article and Find Full Text PDF

Clinical significance of a new diagnosis of atrial fibrillation in patients with vascular disease.

Heart Rhythm

January 2025

Population Health Research Institute, McMaster University, 237 Barton Street East, Hamilton, ON, L8L 2X2, Ontario, Canada.

Background: The Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) trial enrolled patients with vascular disease, but excluded patients requiring oral anticoagulation.

Objective: To explore the clinical significance of a new diagnosis of atrial fibrillation (AF) during follow-up.

Methods: New AF was identified from hospitalization, study drug discontinuation and adverse event reports.

View Article and Find Full Text PDF

Investigation into Drug-Induced Liver Damage Using Multimodal Mass Spectrometry Imaging.

J Am Soc Mass Spectrom

January 2025

Maastricht MultiModal Molecular Imaging Institute (M4i), Division of Imaging Mass Spectrometry, Maastricht University, Universiteitssingel 50, 6229 ER Maastricht, The Netherlands.

Drug toxicity during the development of candidate pharmaceuticals is the leading cause of discontinuation in preclinical drug discovery and development. Traditionally, the cause of the toxicity is often determined by histological examination, clinical pathology, and the detection of drugs and/or metabolites by liquid chromatography-mass spectrometry (LC-MS). While these techniques individually provide information on the pathological effects of the drug and the detection of metabolites, they cannot provide specific molecular spatial information without additional experiments.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!